Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

AbCellera Biologics Inc. ABCL

Set alert

Price alert · ABCL

All alert types
12.04 USD +0.92 +8.27%

As of Nov 3, 11:20 AM ET

Bid
12.02 × 2
Ask
12.03 × 2
11.28 Day range 12.33
2.75 52-week range 15.02
YTD
+252.05%
1 year
+124.21%
Open
11.31
Prev close
11.12
Mkt cap
3.90B
Vol
885.62K
Avg vol
6.40M
EPS
-0.54
P/E
0.00
Div yield
0.00%
More statistics
Low
11.28
High
12.33
Forward P/E
-14.58
Beta
1.59
Short ratio
5.65
Inst. own
40.76%
Dividend
0.00
Ex-div date
Earnings
Nov 9, 2026
50-d avg
12.29
200-d avg
6.85
1y target
17.17

5D chart

Chart tools
Interval
1m5m15m30m

Signals (95)
NameTimeAgo
MACD: Sell SignalNov 3, 10:55 AM26 minutes ago
SMA: BearishNov 3, 10:50 AM31 minutes ago
SMA: BullishNov 3, 9:30 AM1 hour ago
SMA: BullishNov 3, 9:30 AM1 hour ago
MACD: Buy SignalNov 3, 9:30 AM1 hour ago
RSI: OverboughtNov 3, 9:30 AM1 hour ago
MACD: Sell SignalNov 2, 3:35 PM19 hours ago
SMA: BearishNov 2, 3:30 PM19 hours ago
SMA: BearishNov 2, 3:25 PM19 hours ago
SMA: BullishNov 2, 3:15 PM20 hours ago
SMA: BearishNov 2, 3:10 PM20 hours ago
SMA: BullishNov 2, 3:05 PM20 hours ago
SMA: BullishNov 2, 3:05 PM20 hours ago
SMA: BearishNov 2, 3:00 PM20 hours ago
SMA: BullishNov 2, 2:55 PM20 hours ago
MACD: Buy SignalNov 2, 2:55 PM20 hours ago
MACD: Sell SignalNov 2, 2:40 PM20 hours ago
SMA: BearishNov 2, 2:15 PM21 hours ago
SMA: BullishNov 2, 2:10 PM21 hours ago
MACD: Buy SignalNov 2, 2:10 PM21 hours ago

Newest 20 of 95.

Financial health

Altman Z-Score

5.23 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

3 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C2 / 5 overall

  • DCF 1
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 3
  • P/E 1
  • P/B 3

Valuation

P/E -7.0×
FY 2018: 29450×FY 2019: -5718×FY 2020: 89.4×FY 2021: 25.5×FY 2022: 18.1×FY 2023: -11.2×FY 2024: -5.3×FY 2025: -7.0×
FY 2018 5y median -5.3× FY 2025
P/S 13.6×
FY 2018: 1007×FY 2019: 1093×FY 2020: 45.4×FY 2021: 10.5×FY 2022: 5.9×FY 2023: 43.4×FY 2024: 29.9×FY 2025: 13.6×
FY 2018 5y median 13.6× FY 2025
P/B 1.1×
FY 2018: 766×FY 2019: 1238×FY 2020: 12.7×FY 2021: 3.8×FY 2022: 2.3×FY 2023: 1.4×FY 2024: 0.8×FY 2025: 1.1×
FY 2018 5y median 1.4× FY 2025
P/FCF -5.9×
FY 2018: -5107×FY 2019: -9737×FY 2020: 1321×FY 2021: 21.2×FY 2022: 14.1×FY 2023: -13.6×FY 2024: -4.6×FY 2025: -5.9×
FY 2018 5y median -4.6× FY 2025
EV/EBITDA -7.0×
FY 2018: 6177×FY 2019: -81853×FY 2020: 59.0×FY 2021: 14.7×FY 2022: 9.9×FY 2023: -8.3×FY 2024: -3.8×FY 2025: -7.0×
FY 2018 5y median -3.8× FY 2025
EV/Sales 13.8×
FY 2018: 1007×FY 2019: 1093×FY 2020: 42.9×FY 2021: 9.3×FY 2022: 5.3×FY 2023: 42.0×FY 2024: 26.8×FY 2025: 13.8×
FY 2018 5y median 13.8× FY 2025
FCF Yield -17.0%
FY 2018: -0.0%FY 2019: -0.0%FY 2020: 0.1%FY 2021: 4.7%FY 2022: 7.1%FY 2023: -7.4%FY 2024: -21.7%FY 2025: -17.0%
FY 2018 5y median -7.4% FY 2025

Profitability

Gross Margin 61.6%
FY 2018: 100.0%FY 2019: 100.0%FY 2020: 88.4%FY 2021: 87.9%FY 2022: 86.3%FY 2023: 100.0%FY 2024: 100.0%FY 2025: 61.6%
FY 2018 5y median 87.9% FY 2025
Operating Margin -289.0%
FY 2018: -8.5%FY 2019: -35.5%FY 2020: 66.9%FY 2021: 54.5%FY 2022: 44.6%FY 2023: -623.8%FY 2024: -1091.7%FY 2025: -289.0%
FY 2018 5y median -289.0% FY 2025
Net Margin -194.9%
FY 2018: 3.5%FY 2019: -19.0%FY 2020: 51.0%FY 2021: 40.9%FY 2022: 32.7%FY 2023: -385.0%FY 2024: -564.8%FY 2025: -194.9%
FY 2018 5y median -194.9% FY 2025
ROE -15.1%
FY 2018: 2.7%FY 2019: -21.6%FY 2020: 14.3%FY 2021: 15.0%FY 2022: 12.9%FY 2023: -12.7%FY 2024: -15.4%FY 2025: -15.1%
FY 2018 5y median -12.7% FY 2025
ROIC -13.8%
FY 2018: -4.3%FY 2019: -22.3%FY 2020: 13.0%FY 2021: 11.9%FY 2022: 10.1%FY 2023: -14.5%FY 2024: -19.9%FY 2025: -13.8%
FY 2018 5y median -13.8% FY 2025
ROA -10.8%
FY 2018: 1.4%FY 2019: -9.4%FY 2020: 11.8%FY 2021: 11.6%FY 2022: 10.3%FY 2023: -9.8%FY 2024: -12.0%FY 2025: -10.8%
FY 2018 5y median -9.8% FY 2025

Growth (YoY)

Revenue 160.6%
FY 2018: 0.0%FY 2019: 31.5%FY 2020: 1907.9%FY 2021: 60.9%FY 2022: 29.4%FY 2023: -92.2%FY 2024: -24.2%FY 2025: 160.6%
FY 2018 FY 2025
Operating Income 31.0%
FY 2018: 0.0%FY 2019: -446.7%FY 2020: 3889.9%FY 2021: 31.0%FY 2022: 5.9%FY 2023: -209.6%FY 2024: -32.7%FY 2025: 31.0%
FY 2018 FY 2025
EPS (diluted) 10.9%
FY 2018: 0.0%FY 2019: -615.0%FY 2020: 4468.9%FY 2021: 6.7%FY 2022: 4.2%FY 2023: -202.0%FY 2024: -7.8%FY 2025: 10.9%
FY 2018 FY 2025
Free Cash Flow 6.9%
FY 2018: 0.0%FY 2019: 25.2%FY 2020: 715.3%FY 2021: 2221.7%FY 2022: 10.0%FY 2023: -159.3%FY 2024: -54.0%FY 2025: 6.9%
FY 2018 FY 2025

Financial Health

Current Ratio 11.3×
FY 2018: 2.4×FY 2019: 1.6×FY 2020: 7.9×FY 2021: 7.7×FY 2022: 8.7×FY 2023: 7.3×FY 2024: 9.8×FY 2025: 11.3×
FY 2018 5y median 8.7× FY 2025
Quick Ratio 11.2×
FY 2018: 2.4×FY 2019: 1.6×FY 2020: 7.8×FY 2021: 7.7×FY 2022: 8.7×FY 2023: 7.3×FY 2024: 9.8×FY 2025: 11.2×
FY 2018 5y median 8.7× FY 2025
Debt / Equity 0.1×
FY 2018: 0.3×FY 2019: 0.7×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.1×FY 2023: 0.1×FY 2024: 0.1×FY 2025: 0.1×
FY 2018 5y median 0.1× FY 2025
Net Debt / EBITDA -0.1×
FY 2018: -4.9×FY 2019: 4.3×FY 2020: -3.5×FY 2021: -1.8×FY 2022: -1.2×FY 2023: 0.3×FY 2024: 0.4×FY 2025: -0.1×
FY 2018 5y median -0.1× FY 2025
Interest Coverage 0.0×
FY 2018: -3.6×FY 2019: -19.7×FY 2020: 24.0×FY 2021: 39.1×FY 2022: 53.5×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2018 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2018 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2018 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31